Celecoxib

cytochrome c oxidase II, mitochondrial ; Mus musculus







113 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 22715053 Orally administered rubiscolin-6, a δ opioid peptide derived from Rubisco, stimulates food intake via leptomeningeal lipocallin-type prostaglandin D synthase in mice. 2012 Aug 1
52 22819976 Use of dynamic weight bearing as a novel end-point for the assessment of Freund's Complete Adjuvant induced hypersensitivity in mice. 2012 Aug 30 1
53 22916251 Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice. 2012 1
54 23205124 Effects of cyclooxygenase inhibitors on survival time in ovarian cancer xenograft-bearing mice. 2012 Dec 1
55 21268125 The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. 2011 Jun 1
56 21324324 Microsomal prostaglandin E synthase-1 enhances bone cancer growth and bone cancer-related pain behaviors in mice. 2011 Apr 11 1
57 21456064 Regression of prostate tumors upon combination of hormone ablation therapy and celecoxib in vivo. 2011 Jun 1 2
58 21589914 Altered mRNA editing and expression of ionotropic glutamate receptors after kainic acid exposure in cyclooxygenase-2 deficient mice. 2011 May 12 2
59 21673053 A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. 2011 Jul 1 1
60 21900596 Fluorinated COX-2 inhibitors as agents in PET imaging of inflammation and cancer. 2011 Oct 1
61 21913318 Protection against titanium particle-induced osteoclastogenesis by cyclooxygenase-2 selective inhibitor. 2011 Dec 15 2
62 22140606 Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment. 2011 Jan 10 2
63 20051370 Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice. 2010 Jan 1
64 20124728 Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. 2010 Mar 1
65 20630498 IL-17A stimulates the expression of inflammatory cytokines via celecoxib-blocked prostaglandin in MC3T3-E1 cells. 2010 Sep 1
66 21205474 [Effects of celecoxib combined with fluvastatin on tumor growth and cell apoptosis in a xenograft model of hepatocellular carcinoma]. 2010 Dec 1
67 19159447 n3 and n6 polyunsaturated fatty acids differentially modulate prostaglandin E secretion but not markers of lipogenesis in adipocytes. 2009 Jan 21 1
68 19218449 Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. 2009 Mar 3 1
69 19374162 Celecoxib administration exhibits tissue specific effect on 3H-benzo(a)pyrene-DNA adduct formation in cigarette smoke inhaling mice. 2009 Feb 1
70 19387877 Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin. 2009 Jul 1
71 19470469 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors. 2009 Jun 9 2
72 19800413 Complement C5a stimulates food intake via a prostaglandin D(2)- and neuropeptide Y-dependent mechanism in mice. 2009 Dec 3
73 17950326 The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in apo E-/- mice. 2008 May 1 3
74 18178179 Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. 2008 Feb 8 2
75 18454165 Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. 2008 Jul 1
76 18572215 Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation. 2008 Sep 15 1
77 19216276 Factors influencing effects of specific COX-2 inhibitor NSAIDs on growth and differentiation of mouse osteoblasts on titanium surfaces. 2008 Nov-Dec 1
78 17177201 Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. 2007 Feb 1 3
79 17306872 Pharmacological evaluation of opioid and non-opioid analgesics in a murine bone cancer model of pain. 2007 Mar 1
80 17761345 Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential. 2007 Nov 1
81 16505106 Cyclooxygenase inhibitors in urinary bladder cancer: in vitro and in vivo effects. 2006 Feb 2
82 16534727 Selective inhibition of COX-2 by a standardized CO2 extract of Humulus lupulus in vitro and its activity in a mouse model of zymosan-induced arthritis. 2006 Feb 1
83 16835249 Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway. 2006 Aug 5
84 17049975 Inhibition of the cyclooxygenase pathway attenuates morphine-induced conditioned place preference in mice. 2006 Oct 1
85 17062693 Effect of simultaneous inhibition of epidermal growth factor receptor and cyclooxygenase-2 in HER-2/neu-positive breast cancer. 2006 Oct 15 1
86 15800939 Connexin43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts. 2005 Sep 1 1
87 15860667 Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis. 2005 Aug 15 1
88 15940366 Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles. 2005 Jul 2
89 15999531 Prevention of tumors of the large intestine by celecoxib in mice. 2005 Jul-Aug 1
90 16041399 Ethyl caffeate suppresses NF-kappaB activation and its downstream inflammatory mediators, iNOS, COX-2, and PGE2 in vitro or in mouse skin. 2005 Oct 1
91 16216692 Discrepancy between effects of milligram and nanogram doses of a COX-2 inhibitor (celecoxib) on morphine state-dependent memory of passive avoidance in mice. 2005 Nov 30 2
92 16254252 Cardiovascular complications of non-steroidal anti-inflammatory drugs. 2005 Autumn 1
93 14630706 Genetic deficiency or pharmacological inhibition of cyclooxygenase-1 or -2 induces mouse keratinocyte differentiation in vitro and in vivo. 2004 Jan 1
94 14690522 Modulation of beta-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures. 2004 Jan 1
95 14767831 Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. 2004 Feb 15 1
96 15126378 Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. 2004 May 1 2
97 15170663 Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs. 2004 Jul 20 1
98 15451306 Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice. 2004 Oct 1 1
99 15570007 Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. 2004 Nov 15 2
100 12902868 Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor. 2003 Aug 1